Skip to main content
Log in

High-dose 'flu vaccination saves cost by preventing CVD hospitalisations

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Sanofi Pasteur.

Reference

  • van Aalst R, et al. Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method. Vaccine : 20 Jun 2020. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.05.080

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High-dose 'flu vaccination saves cost by preventing CVD hospitalisations. PharmacoEcon Outcomes News 857, 17 (2020). https://doi.org/10.1007/s40274-020-6954-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6954-7

Navigation